International Cannabis Weekly: 47

• GW Pharmaceuticals close to breakthrough with the FDA.
• Aurora expands German distribution and launches new cannabis brand Klenk.
• Canada’s Speakeasy Cannabis Club signs agreement to export cannabis to Germany.
• Experts gather in London to understand the billion euro European cannabis market.
• Maricann positioned for exports after European Medicines Agency GMP certification.
• Boutique dispensary chain MedMen goes public valued at $1.65 billion.
• Aphria enters the African market with landmark venture in South Africa.

• Majority of Britons support a softer stance on cannabis.
• French Health Minister hints that medical cannabis ‘could happen’.
• Belgian Minister of Public Health on the verge of legalising cannabis oils.
• France’s illicit cannabis trade estimated to be worth €1 billion per annum.
• UK public opinion is changing as experts debate the value of medical cannabis.
• Billy Caldwell forced to leave home to seek treatment.
• Senate candidates cite reasons for cannabis legalisation in Mexico.
• Legalising medical cannabis doesn’t have to lead to legalising recreational use.

• WHO acknowledges cannabis as a ‘relatively safe drug’ during THC review.
• The Guardian delve into the science of CBD.
• Cannabis is increasingly seen as a major player in pain management.
• Cannabis could protect the brain from stress and injury.
• Pet owners are turning to cannabis to treat their dogs.

Prohibition Partners is excited to announce the launch of ‘Medical Cannabis in Europe – The GMP Standards Guide’, in association with Orion GMP Solutions. The Guide is used by manufacturers and legislators to understand the complex network of regulations that will shape the European cannabis market.

A big thank you to everyone who attended the inaugural Cannabis Europa. The sold-out event brought together over 450+ attendees from 25+ countries including industry leaders, politicians, advocates and patients.

We’re already looking forward to the next Cannabis Europa and are committed to our mission of building Europe’s medical cannabis industry.

Sign Up For Future Events